Verrica Pharmaceuticals announces $50M PIPE financing
Source: SeekingAlpha
2025-11-24 08:40:08 ET
More on Verrica Pharmaceuticals
- Verrica Pharmaceuticals Inc. (VRCA) Q3 2025 Earnings Call Transcript
- Verrica targets European expansion for YCANTH as Phase III programs advance and sales force grows
- Seeking Alpha’s Quant Rating on Verrica Pharmaceuticals
- Historical earnings data for Verrica Pharmaceuticals
- Financial information for Verrica Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Verrica Pharmaceuticals announces $50M PIPE financing
Verrica Pharmaceuticals Inc.
NASDAQ: VRCA
VRCA Trading
15.23% G/L:
$6.015 Last:
96,810 Volume:
$5.27 Open:
VRCA Latest News
March 05, 2026 08:00:00 am
Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 11, 2026
February 23, 2026 08:00:00 am
Verrica Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference
February 12, 2026 08:00:00 am
Verrica Pharmaceuticals Appoints Chris Chapman as Chief Commercial Officer
VRCA Stock Data
$98,657,442
3,345,079
4.59%
14
N/A
Biotechnology & Life Sciences
Healthcare
US
West Chester
